Characterization of asymptomatic Plasmodium falciparum infection and its risk factors in pregnant women from the Republic of Congo

• Published in: Acta tropica Vol. 153; pp. 111 - 115
• Main Authors: Francine, Ntoumi, Damien, Bakoua, Anna, Fesser, Michael, Kombo, Christevy, Vouvoungui J., Felix, Koukouikila-Koussounda
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.01.2016
• Subjects: Adolescent; Adult; Antimalarials - therapeutic use; Asymptomatic Infections - epidemiology; Child; Congo - epidemiology; Congo Brazzaville; Cross-Sectional Studies; Female; Humans; Malaria, Falciparum - drug therapy; Malaria, Falciparum - epidemiology; Multiplicity of infection; Plasmodium falciparum; Plasmodium falciparum - drug effects; Pregnancy; Pregnancy Complications, Parasitic - drug therapy; Pregnancy Complications, Parasitic - epidemiology; Pregnant women; Prevalence; Risk Factors; Sulfadoxine - therapeutic use; Young Adult; Congo; Plasmodium falciparum; AOR; Multiplicity of infection; Pregnant women; MOI; IPTp-SP; msp2; LLINs; P. falciparm; Congo Brazzaville; WHO; ACTs
• ISSN: 0001-706X; 1873-6254
• DOI: 10.1016/j.actatropica.2015.10.009

•The first study investigating asymptomatic malaria infection on pregnant women of the Republic of Congo.•High presence of submicroscopic Plasmodium falciparum infection.•Association between malaria sub-microscopic infection and presence of anemia. Malaria in pregnancy remains a serious public health problem in the Republic of Congo despite the implementation of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) in 2006. The aim of this cross-sectional study was to characterize Plasmodium falciparum infections and determine possible risk factors in pregnant Congolese women attending an antenatal clinic in a periurban area of southern Brazzaville. This study was conducted from March 2012 to December 2013 in a site where several years ago, high malaria resistance to SP was reported. Pregnant women were enrolled during antenatal visits and the number of received IPTp-SP doses was recorded as well as individual sociodemographic data. Peripheral blood was collected and P. falciparum infection was checked by microscopy and by PCR targeting P. falciparum merozoite surface protein gene (msp2). Haemoglobin concentration was measured and P. falciparum positive samples were typed for msp2 allelic diversity. A total of 363 pregnant women were recruited. The prevalence of asymptomatic P. falciparum infection was 7% and 19% by microscopy and by PCR, respectively. More than one half (51.5%) of the pregnant women were anaemic. Multivariate analysis indicated that P. falciparum infection was associated with anaemia. It was also observed that women who have received IPTp-SP have significantly lower prevalence of infection. The administration of IPTp-SP did not influence the multiplicity of infection (MOI). This first study investigating asymptomatic malaria infection on pregnant women of the Republic of Congo shows that P. falciparum infections were clearly associated with maternal anaemia, and use of IPTp-SP reduced the risk of carrying asymptomatic infections.